Segment Information (Tables)

3 Months Ended

Dec. 31, 2023

Segment Reporting [Abstract]

Segment Revenue, Operating loss and Depreciation and Amortization

Segment revenue, operating loss, and depreciation and amortization were as follows:

	Three Months Ended December 31,
(In thousands)	2023			2022
Revenue:
Medical Device	$	23,545		$	19,018
In Vitro Diagnostics		7,007			5,915
Total revenue	$	30,552		$	24,933
Operating loss:
Medical Device	$	(224	)	$	(7,235	)
In Vitro Diagnostics		3,124			2,948
Total segment operating income (loss)		2,900			(4,287	)
Corporate		(3,222	)		(2,942	)
Total operating loss	$	(322	)	$	(7,229	)
Depreciation and amortization:
Medical Device	$	2,054		$	1,953
In Vitro Diagnostics		97			77
Corporate		182			92
Total depreciation and amortization	$	2,333		$	2,122